News
American Society of Hematology (ASH) Annual Meeting Update
Several presentations were delivered by independent experts at the prestigious 58th ASH Annual Meeting that summarised studies using Resonance Health’s FerriScan® technology. The studies demonstrated the broadening acceptance of FerriScan
Results Published Recommending Use of FerriScan in Sickle Cell Disease
FerriScan has received further endorsement for the management of patients with Sickle Cell Disease (SCD) in apaper recently published by the highly respected Dr Janet Kwiatkowski team at the Children’s
Resonance Health News – September 2016
We are very pleased to provide an update of our most recent and upcoming activities. It has been a very productive quarter and we look forwards to further progressing our
New FerriScan Video – A Clinician’s Perspective
We are delighted to present a short interview filmed between Resonance Health's Chief Scientific Officer, Prof. Tim St Pierre, and Dr Josu de la Fuente, a Consultant Paediatric Haematologist and
Iron Monitoring in Cancer Survivors – Clinician Survey
Iron Overload is increasingly recognised as a possible complication for cancer survivors who have received multiple blood transfusions during their cancer treatment. FerriScan can reliably and accurately screen for Iron Overload
Video Launch: “FerriScan – the Gold Standard in Liver Iron Measurement”
Resonance Health proudly presents our new video "FerriScan – the Gold Standard in Liver Iron Measurement"….